Ranmali Ranasinghe

474 total citations
11 papers, 301 citations indexed

About

Ranmali Ranasinghe is a scholar working on Oncology, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, Ranmali Ranasinghe has authored 11 papers receiving a total of 301 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 4 papers in Immunology and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Ranmali Ranasinghe's work include Chemokine receptors and signaling (3 papers), Chemotherapy-induced organ toxicity mitigation (2 papers) and T-cell and B-cell Immunology (2 papers). Ranmali Ranasinghe is often cited by papers focused on Chemokine receptors and signaling (3 papers), Chemotherapy-induced organ toxicity mitigation (2 papers) and T-cell and B-cell Immunology (2 papers). Ranmali Ranasinghe collaborates with scholars based in Australia, Malaysia and Sri Lanka. Ranmali Ranasinghe's co-authors include Michael L. Mathai, Anthony Zulli, Rajaraman Eri, Mohammed Abdullah Alshawsh, Ruchira Fernando, Madhur D. Shastri, Dharshana Kasthurirathna and Agampodi Promoda Perera and has published in prestigious journals such as SHILAP Revista de lepidopterología, Life Sciences and Biochimica et Biophysica Acta (BBA) - Reviews on Cancer.

In The Last Decade

Ranmali Ranasinghe

10 papers receiving 294 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ranmali Ranasinghe Australia 8 92 85 73 39 32 11 301
Sara Ciuffa Italy 10 126 1.4× 77 0.9× 52 0.7× 28 0.7× 32 1.0× 12 281
Kavitha Godugu United States 12 136 1.5× 62 0.7× 51 0.7× 21 0.5× 13 0.4× 29 350
Anisha Kothari United States 6 262 2.8× 88 1.0× 49 0.7× 40 1.0× 25 0.8× 9 465
Konrad Zaręba Poland 11 161 1.8× 131 1.5× 48 0.7× 47 1.2× 66 2.1× 46 436
Kuo-Juei Lin Taiwan 9 114 1.2× 47 0.6× 66 0.9× 46 1.2× 23 0.7× 12 400
Li Hou China 12 129 1.4× 89 1.0× 50 0.7× 29 0.7× 31 1.0× 38 377
Fan He China 11 200 2.2× 69 0.8× 67 0.9× 21 0.5× 15 0.5× 32 447
Jonathan Eckard United States 6 103 1.1× 60 0.7× 29 0.4× 24 0.6× 28 0.9× 10 362
Zheng Song China 8 149 1.6× 116 1.4× 83 1.1× 62 1.6× 23 0.7× 27 314
Caroline Decombat France 8 84 0.9× 113 1.3× 75 1.0× 20 0.5× 23 0.7× 20 288

Countries citing papers authored by Ranmali Ranasinghe

Since Specialization
Citations

This map shows the geographic impact of Ranmali Ranasinghe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ranmali Ranasinghe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ranmali Ranasinghe more than expected).

Fields of papers citing papers by Ranmali Ranasinghe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ranmali Ranasinghe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ranmali Ranasinghe. The network helps show where Ranmali Ranasinghe may publish in the future.

Co-authorship network of co-authors of Ranmali Ranasinghe

This figure shows the co-authorship network connecting the top 25 collaborators of Ranmali Ranasinghe. A scholar is included among the top collaborators of Ranmali Ranasinghe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ranmali Ranasinghe. Ranmali Ranasinghe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Ranasinghe, Ranmali, Michael L. Mathai, Mohammed Abdullah Alshawsh, & Anthony Zulli. (2024). Nanocarrier-mediated cancer therapy with cisplatin: A meta-analysis with a promising new paradigm. Heliyon. 10(7). e28171–e28171. 2 indexed citations
2.
Ranasinghe, Ranmali, Michael L. Mathai, & Anthony Zulli. (2023). Cytoprotective remedies for ameliorating nephrotoxicity induced by renal oxidative stress. Life Sciences. 318. 121466–121466. 31 indexed citations
3.
Ranasinghe, Ranmali, Michael L. Mathai, & Anthony Zulli. (2022). Revisiting the therapeutic potential of tocotrienol. BioFactors. 48(4). 813–856. 38 indexed citations
4.
Ranasinghe, Ranmali, Michael L. Mathai, & Anthony Zulli. (2022). Cisplatin for cancer therapy and overcoming chemoresistance. Heliyon. 8(9). e10608–e10608. 95 indexed citations
5.
Ranasinghe, Ranmali, Michael L. Mathai, & Anthony Zulli. (2022). A synopsis of modern - day colorectal cancer: Where we stand. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1877(2). 188699–188699. 27 indexed citations
7.
Ranasinghe, Ranmali, et al.. (2020). Ccr6 Deficiency Attenuates Spontaneous Chronic Colitis in Winnie. SHILAP Revista de lepidopterología. 2(1). 27–47. 2 indexed citations
8.
Ranasinghe, Ranmali & Rajaraman Eri. (2018). CCR6–CCL20-Mediated Immunologic Pathways in Inflammatory Bowel Disease. Gastrointestinal Disorders. 1(1). 15–29. 9 indexed citations
9.
Ranasinghe, Ranmali & Rajaraman Eri. (2018). CCR6–CCL20 Axis in IBD: What Have We Learnt in the Last 20 Years?. Gastrointestinal Disorders. 1(1). 57–74. 7 indexed citations
10.
Ranasinghe, Ranmali & Rajaraman Eri. (2018). Modulation of the CCR6-CCL20 Axis: A Potential Therapeutic Target in Inflammation and Cancer. Medicina. 54(5). 88–88. 54 indexed citations
11.
Ranasinghe, Ranmali & Rajaraman Eri. (2018). Pleiotropic Immune Functions of Chemokine Receptor 6 in Health and Disease. SHILAP Revista de lepidopterología. 5(3). 69–69. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026